Daniel P Poole Selected Research

Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)

1/2017

G-CSF Receptor Blockade Ameliorates Arthritic Pain and Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel P Poole Research Topics

Disease

20	Pain (Aches) 01/2022 - 09/2009
17	Inflammation (Inflammations) 01/2022 - 10/2007
6	Colitis 01/2022 - 08/2015
5	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2022 - 08/2015
5	Hyperalgesia 01/2022 - 09/2009
5	Neurogenic Inflammation 01/2020 - 07/2008
4	Constipation 01/2022 - 01/2013
4	Chronic Pain 01/2022 - 01/2015
3	Diarrhea 01/2022 - 01/2013
3	Hypersensitivity (Allergy) 01/2020 - 08/2015
2	Arthritis (Polyarthritis) 01/2022 - 01/2017
2	Edema (Dropsy) 01/2021 - 01/2020
2	Chronic Disease (Chronic Diseases) 01/2020 - 01/2017
2	Pruritus (Itching) 12/2014 - 04/2013
1	Pulmonary Edema 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Neuralgia (Stump Neuralgia) 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2020
1	Legionnaires' Disease (Legionnaire's Disease) 01/2019
1	Mouth Neoplasms (Oral Cancer) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Infections 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 10/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Malaria 01/2017
1	Cough 01/2015

Drug/Important Bio-Agent (IBA)

8	Ion Channels (Ion Channel)IBA 01/2021 - 07/2008
7	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 02/2013
6	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2022 - 05/2014
6	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020 - 02/2013
6	Opioid Analgesics (Opioids)IBA 01/2020 - 04/2013
4	PAR-2 ReceptorIBA 01/2022 - 09/2009
4	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2022 - 08/2019
4	Substance PIBA 12/2019 - 05/2014
4	Bile Acids and Salts (Bile Acids)IBA 12/2014 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
3	Analgesics (Analgesic Drugs)IBA 01/2020 - 01/2019
2	CytokinesIBA 01/2022 - 01/2019
2	Protein Isoforms (Isoforms)IBA 01/2022 - 10/2007
2	Aprepitant (Emend)FDA Link 01/2022 - 12/2019
2	Neurokinin-1 Receptor AntagonistsIBA 01/2022 - 01/2021
2	ArrestinIBA 01/2022 - 02/2013
2	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2020 - 08/2019
2	Irritants (Vesicants)IBA 10/2019 - 01/2015
2	Serine Proteases (Serine Protease)IBA 01/2019 - 09/2009
2	Capsaicin (Zostrix)FDA Link 11/2017 - 07/2008
2	Transient Receptor Potential ChannelsIBA 08/2015 - 01/2015
2	AnkyrinsIBA 12/2014 - 08/2011
2	NeuropeptidesIBA 02/2013 - 12/2009
2	Protein Kinase CIBA 09/2009 - 10/2007
1	AminesIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	PolymersIBA 01/2022
1	Castor Oil (Oil, Castor)IBA 01/2022
1	Proteinase-Activated ReceptorsIBA 01/2022
1	Dynamin IIIBA 01/2022
1	BMS-986187IBA 01/2022
1	Opioid Receptors (Opioid Receptor)IBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	LipidsIBA 01/2021
1	Thrombin FDA Link 01/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	eluxadolineIBA 01/2020
1	Tissue ExtractsIBA 01/2019
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Dextran SulfateIBA 10/2018
1	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 10/2018
1	TrypsinIBA 01/2018
1	Pancreatic Elastase (Elastase)IBA 01/2018
1	ClathrinIBA 01/2018
1	Dynamins (Dynamin)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	cathepsin SIBA 01/2018
1	ivacaftor drug combination lumacaftorIBA 01/2018
1	ivacaftorIBA 01/2018
1	Formaldehyde (Formol)FDA Link 11/2017
1	calcitonin gene-related peptide (8-37)IBA 11/2017
1	Calcitonin Gene-Related PeptideIBA 11/2017
1	Calcitonin Receptor-Like ProteinIBA 11/2017
1	Freund's AdjuvantIBA 11/2017
1	Cell Surface ReceptorsIBA 01/2017
1	ZymosanIBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 01/2017
1	Interleukin-12 (IL 12)IBA 01/2017
1	Interleukin-18 (Interleukin 18)IBA 01/2017
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2017
1	CRT 0066101IBA 05/2016
1	Interleukin-10 (Interleukin 10)IBA 08/2015
1	Piroxicam (Feldene)FDA LinkGeneric 08/2015
1	Trinitrobenzenesulfonic AcidIBA 08/2015
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2015
1	5,6-epoxy-8,11,14-eicosatrienoic acidIBA 08/2015
1	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 08/2015
1	Small Interfering RNA (siRNA)IBA 08/2015

Therapy/Procedure

5	Therapeutics 01/2020 - 09/2010
2	Spinal Injections 12/2019 - 08/2015
1	Injections 08/2015